{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T06:49:51Z","timestamp":1751957391457},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,3,29]],"date-time":"2014-03-29T00:00:00Z","timestamp":1396051200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Genet Med Rep"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1007\/s40142-014-0035-9","type":"journal-article","created":{"date-parts":[[2014,3,28]],"date-time":"2014-03-28T20:10:56Z","timestamp":1396037456000},"page":"75-84","source":"Crossref","is-referenced-by-count":9,"title":["Rare Variants and Transcriptomics in Alzheimer disease"],"prefix":"10.1007","volume":"2","author":[{"given":"Crystal","family":"Humphries","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin A.","family":"Kohli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,29]]},"reference":[{"issue":"2","key":"35_CR1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.31887\/DCNS.2009.11.2\/cqiu","volume":"11","author":"C Qiu","year":"2009","unstructured":"Qiu C, Kivipelto M, von Strauss E. Epidemiology of Alzheimer\u2019s disease: occurrence, determinants, and strategies toward intervention. Dialogues Clin Neurosci. 2009;11(2):111\u201328.","journal-title":"Dialogues Clin Neurosci."},{"issue":"9","key":"35_CR2","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.disamonth.2010.06.001","volume":"56","author":"RJ Castellani","year":"2010","unstructured":"Castellani RJ, Rolston RK, Smith MA. Alzheimer disease. Dis Mon. 2010;56(9):484\u2013546.","journal-title":"Dis Mon"},{"issue":"5580","key":"35_CR3","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science. 2002;297(5580):353\u20136.","journal-title":"Science"},{"issue":"4","key":"35_CR4","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82(4):239\u201359.","journal-title":"Acta Neuropathol"},{"issue":"2","key":"35_CR5","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1001\/archpsyc.63.2.168","volume":"63","author":"M Gatz","year":"2006","unstructured":"Gatz M, Reynolds CA, Fratiglioni L, Johansson B, Mortimer JA, Berg S, et al. Role of genes and environments for explaining Alzheimer disease. Arch Gen Psychiatry. 2006;63(2):168\u201374.","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"35_CR6","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1086\/302553","volume":"65","author":"D Campion","year":"1999","unstructured":"Campion D, Dumanchin C, Hannequin D, Dubois B, Belliard S, Puel M, et al. Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum. Am J Hum Genet. 1999;65(3):664\u201370.","journal-title":"Am J Hum Genet"},{"issue":"6","key":"35_CR7","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1212\/WNL.39.6.773","volume":"39","author":"E Kokmen","year":"1989","unstructured":"Kokmen E, Beard CM, Offord KP, Kurland LT. Prevalence of medically diagnosed dementia in a defined United States population: Rochester, Minnesota, January 1, 1975. Neurology. 1989;39(6):773\u20136.","journal-title":"Neurology."},{"issue":"6311","key":"35_CR8","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/349704a0","volume":"349","author":"A Goate","year":"1991","unstructured":"Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer\u2019s disease. Nature. 1991;349(6311):704\u20136.","journal-title":"Nature"},{"issue":"4791","key":"35_CR9","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1126\/science.2880399","volume":"235","author":"PH St George-Hyslop","year":"1987","unstructured":"St George-Hyslop PH, Tanzi RE, Polinsky RJ, Haines JL, Nee L, Watkins PC, et al. The genetic defect causing familial Alzheimer\u2019s disease maps on chromosome 21. Science. 1987;235(4791):885\u201390.","journal-title":"Science"},{"issue":"5082","key":"35_CR10","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1126\/science.1411576","volume":"258","author":"GD Schellenberg","year":"1992","unstructured":"Schellenberg GD, Bird TD, Wijsman EM, Orr HT, Anderson L, Nemens E, et al. Genetic linkage evidence for a familial Alzheimer\u2019s disease locus on chromosome 14. Science. 1992;258(5082):668\u201371.","journal-title":"Science"},{"issue":"6534","key":"35_CR11","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/375754a0","volume":"375","author":"R Sherrington","year":"1995","unstructured":"Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer\u2019s disease. Nature. 1995;375(6534):754\u201360.","journal-title":"Nature"},{"issue":"5226","key":"35_CR12","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1126\/science.7638621","volume":"269","author":"E Levy-Lahad","year":"1995","unstructured":"Levy-Lahad E, Wijsman EM, Nemens E, Anderson L, Goddard KA, Weber JL, et al. A familial Alzheimer\u2019s disease locus on chromosome 1. Science. 1995;269(5226):970\u20133.","journal-title":"Science"},{"issue":"6543","key":"35_CR13","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/376775a0","volume":"376","author":"EI Rogaev","year":"1995","unstructured":"Rogaev EI, Sherrington R, Rogaeva EA, Levesque G, Ikeda M, Liang Y, et al. Familial Alzheimer\u2019s disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer\u2019s disease type 3 gene. Nature. 1995;376(6543):775\u20138.","journal-title":"Nature"},{"key":"35_CR14","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Cruts M, Theuns J, Van Broeckhoven C. Locus-specific mutation databases for neurodegenerative brain diseases. Hum Mutat. 2012;33(9):1340\u20134. Alzheimer Disease & Frontotemporal Dementia Mutation Database: www.molgen.ua.ac.be\/ADMutations .","DOI":"10.1002\/humu.22117"},{"key":"35_CR15","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Ringman JM, Coppola G. New genes and new insights from old genes: update on Alzheimer disease. Continuum (Minneap Minn). 2013;19(2 Dementia):358\u201371. Review on clinical aspects of genetic variants in Alzheimer disease.","DOI":"10.1212\/01.CON.0000429179.21977.a1"},{"issue":"6665","key":"35_CR16","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/34910","volume":"391","author":"B Strooper De","year":"1998","unstructured":"De Strooper B, Saftig P, Craessaerts K, Vanderstichele H, Guhde G, Annaert W, et al. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature. 1998;391(6665):387\u201390.","journal-title":"Nature"},{"issue":"Suppl 1","key":"35_CR17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1471-4159.2011.07575.x","volume":"120","author":"A Goate","year":"2012","unstructured":"Goate A, Hardy J. Twenty years of Alzheimer\u2019s disease-causing mutations. J Neurochem. 2012;120(Suppl 1):3\u20138.","journal-title":"J Neurochem"},{"issue":"6","key":"35_CR18","first-page":"1034","volume":"48","author":"MA Pericak-Vance","year":"1991","unstructured":"Pericak-Vance MA, Bebout JL, Gaskell PC Jr, Yamaoka LH, Hung WY, Alberts MJ, et al. Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage. Am J Hum Genet. 1991;48(6):1034\u201350.","journal-title":"Am J Hum Genet"},{"issue":"5123","key":"35_CR19","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families. Science. 1993;261(5123):921\u20133.","journal-title":"Science"},{"issue":"12","key":"35_CR20","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0168-9525(00)89161-1","volume":"11","author":"MA Pericak-Vance","year":"1995","unstructured":"Pericak-Vance MA, Haines JL. Genetic susceptibility to Alzheimer disease. Trends Genet. 1995;11(12):504\u20138.","journal-title":"Trends Genet"},{"issue":"16","key":"35_CR21","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","volume":"278","author":"LA Farrer","year":"1997","unstructured":"Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA. 1997;278(16):1349\u201356.","journal-title":"JAMA"},{"issue":"3","key":"35_CR22","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.neuron.2009.06.026","volume":"63","author":"J Kim","year":"2009","unstructured":"Kim J, Basak JM, Holtzman DM. The role of apolipoprotein E in Alzheimer\u2019s disease. Neuron. 2009;63(3):287\u2013303.","journal-title":"Neuron"},{"issue":"1","key":"35_CR23","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S1474-4422(12)70259-4","volume":"12","author":"K Bettens","year":"2013","unstructured":"Bettens K, Sleegers K, Van Broeckhoven C. Genetic insights in Alzheimer\u2019s disease. Lancet Neurol. 2013;12(1):92\u2013104.","journal-title":"Lancet Neurol"},{"key":"35_CR24","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C, et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease. Nat Genet. 2013;45(12):1452\u20138. Latest GWAS on late-onset Alzheimer disease by the International Genomics of Alzheimer Disease Project (IGAP).","DOI":"10.1038\/ng.2802"},{"issue":"7265","key":"35_CR25","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/nature08494","volume":"461","author":"TA Manolio","year":"2009","unstructured":"Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, et al. Finding the missing heritability of complex diseases. Nature. 2009;461(7265):747\u201353.","journal-title":"Nature"},{"key":"35_CR26","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, Snaedal J, et al. Variant of TREM2 associated with the risk of Alzheimer\u2019s disease. N Engl J Med. 2013;368(2):107\u201316. Identification of TREM2 as a novel LOAD susceptibility gene. The rare variant p.R47H confers similarly large risk to late-onset AD as the APOE \u03b54 allele.","DOI":"10.1056\/NEJMoa1211103"},{"key":"35_CR27","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Cruchaga C, Haller G, Chakraverty S, Mayo K, Vallania FL, Mitra RD, et al. Rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer\u2019s disease families. PLoS One. 2012;7(2):e31039. ADEOAD genes (APP, PSEN1 and 2) overall show an overrepresentation of rare coding variants in late-onset Alzheimer disease subjects.","DOI":"10.1371\/journal.pone.0031039"},{"key":"35_CR28","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Jonsson T, Atwal JK, Steinberg S, Snaedal J, Jonsson PV, Bjornsson S, et al. A mutation in APP protects against Alzheimer\u2019s disease and age-related cognitive decline. Nature. 2012;488(7409):96\u20139. Identification of the rare APP p.A673T substitution that protects from AD with large effect size through reduced A\u03b2-cleavage.","DOI":"10.1038\/nature11283"},{"key":"35_CR29","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, et al. TREM2 variants in Alzheimer\u2019s disease. N Engl J Med. 2013;368(2):117\u201327. Identification of TREM2 as a novel LOAD susceptibility gene. The rare variant p.R47H confers similarly large risk to late-onset AD as the APOE \u03b54 allele.","DOI":"10.1056\/NEJMoa1211851"},{"key":"35_CR30","unstructured":"\u2022\u2022 Cruchaga C, Karch CM, Jin SC, Benitez BA, Cai Y, Guerreiro R, et al. Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer\u2019s disease. Nature. 2013. Identification of PLD3 as a novel LOAD susceptibility gene in a combined approach of sequencing of LOAD families, large cohort genotyping and gene-based sequencing association analyses."},{"issue":"5","key":"35_CR31","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ng0892-345","volume":"1","author":"M Mullan","year":"1992","unstructured":"Mullan M, Crawford F, Axelman K, Houlden H, Lilius L, Winblad B, et al. A pathogenic mutation for probable Alzheimer\u2019s disease in the APP gene at the N\u2013terminus of \u03b2\u2013amyloid. Nat Genet. 1992;1(5):345\u20137.","journal-title":"Nat Genet"},{"issue":"12","key":"35_CR32","first-page":"e27","volume":"2319","author":"D Avramopoulos","year":"2011","unstructured":"Avramopoulos D, Szymanski M, Wang R, Bassett S. Gene expression reveals overlap between normal aging and Alzheimer\u2019s disease genes. Neurobiol Aging. 2011;2319(12):e27\u201334.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"35_CR33","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.brainres.2006.09.106","volume":"1127","author":"WM Brooks","year":"2007","unstructured":"Brooks WM, Lynch PJ, Ingle CC, Hatton A, Emson PC, Faull RL, et al. Gene expression profiles of metabolic enzyme transcripts in Alzheimer\u2019s disease. Brain Res. 2007;1127(1):127\u201335.","journal-title":"Brain Res"},{"issue":"9","key":"35_CR34","doi-asserted-by":"crossref","first-page":"e13098","DOI":"10.1371\/journal.pone.0013098","volume":"5","author":"K Cao","year":"2010","unstructured":"Cao K, Chen-Plotkin AS, Plotkin JB, Wang LS. Age-correlated gene expression in normal and neurodegenerative human brain tissues. PLoS One. 2010;5(9):e13098.","journal-title":"PLoS One"},{"issue":"10","key":"35_CR35","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.neurobiolaging.2005.08.013","volume":"27","author":"T Dunckley","year":"2006","unstructured":"Dunckley T, Beach TG, Ramsey KE, Grover A, Mastroeni D, Walker DG, et al. Gene expression correlates of neurofibrillary tangles in Alzheimer\u2019s disease. Neurobiol Aging. 2006;27(10):1359\u201371.","journal-title":"Neurobiol Aging"},{"issue":"3","key":"35_CR36","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.nbd.2005.09.004","volume":"21","author":"L Emilsson","year":"2006","unstructured":"Emilsson L, Saetre P, Jazin E. Alzheimer\u2019s disease: mRNA expression profiles of multiple patients show alterations of genes involved with calcium signaling. Neurobiol Dis. 2006;21(3):618\u201325.","journal-title":"Neurobiol Dis"},{"issue":"4","key":"35_CR37","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.neurobiolaging.2007.07.021","volume":"30","author":"V Haroutunian","year":"2009","unstructured":"Haroutunian V, Katsel P, Schmeidler J. Transcriptional vulnerability of brain regions in Alzheimer\u2019s disease and dementia. Neurobiol Aging. 2009;30(4):561\u201373.","journal-title":"Neurobiol Aging"},{"issue":"3","key":"35_CR38","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1468-1331.2010.03166.x","volume":"18","author":"Y Horesh","year":"2011","unstructured":"Horesh Y, Katsel P, Haroutunian V, Domany E. Gene expression signature is shared by patients with Alzheimer\u2019s disease and schizophrenia at the superior temporal gyrus. Eur J Neurol. 2011;18(3):410\u201324.","journal-title":"Eur J Neurol"},{"issue":"4\u20135","key":"35_CR39","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s11064-007-9297-x","volume":"32","author":"P Katsel","year":"2007","unstructured":"Katsel P, Li C, Haroutunian V. Gene expression alterations in the sphingolipid metabolism pathways during progression of dementia and Alzheimer\u2019s disease: a shift toward ceramide accumulation at the earliest recognizable stages of Alzheimer\u2019s disease? Neurochem Res. 2007;32(4\u20135):845\u201356.","journal-title":"Neurochem Res"},{"issue":"10","key":"35_CR40","doi-asserted-by":"crossref","first-page":"e7642","DOI":"10.1371\/journal.pone.0007642","volume":"4","author":"P Katsel","year":"2009","unstructured":"Katsel P, Tan W, Haroutunian V. Gain in brain immunity in the oldest-old differentiates cognitively normal from demented individuals. PLoS One. 2009;4(10):e7642.","journal-title":"PLoS One"},{"issue":"6","key":"35_CR41","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1023\/B:NERE.0000023615.89699.63","volume":"29","author":"WJ Lukiw","year":"2004","unstructured":"Lukiw WJ. Gene expression profiling in fetal, aged, and Alzheimer hippocampus: a continuum of stress-related signaling. Neurochem Res. 2004;29(6):1287\u201397.","journal-title":"Neurochem Res"},{"key":"35_CR42","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.neulet.2012.12.042","volume":"536","author":"JD Mills","year":"2013","unstructured":"Mills JD, Nalpathamkalam T, Jacobs HI, Janitz C, Merico D, Hu P, et al. RNA-Seq analysis of the parietal cortex in Alzheimer\u2019s disease reveals alternatively spliced isoforms related to lipid metabolism. Neurosci Lett. 2013;536:90\u20135.","journal-title":"Neurosci Lett"},{"issue":"12","key":"35_CR43","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/j.neurobiolaging.2006.08.014","volume":"28","author":"A Parachikova","year":"2007","unstructured":"Parachikova A, Agadjanyan MG, Cribbs DH, Blurton-Jones M, Perreau V, Rogers J, et al. Inflammatory changes parallel the early stages of Alzheimer disease. Neurobiol Aging. 2007;28(12):1821\u201333.","journal-title":"Neurobiol Aging"},{"issue":"11","key":"35_CR44","doi-asserted-by":"crossref","first-page":"e48751","DOI":"10.1371\/journal.pone.0048751","volume":"7","author":"AR Silva","year":"2012","unstructured":"Silva AR, Grinberg LT, Farfel JM, Diniz BS, Lima LA, Silva PJ, et al. Transcriptional alterations related to neuropathology and clinical manifestation of Alzheimer\u2019s disease. PLoS One. 2012;7(11):e48751.","journal-title":"PLoS One"},{"issue":"6","key":"35_CR45","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jnr.22290","volume":"88","author":"MG Tan","year":"2010","unstructured":"Tan MG, Chua WT, Esiri MM, Smith AD, Vinters HV, Lai MK. Genome wide profiling of altered gene expression in the neocortex of Alzheimer\u2019s disease. J Neurosci Res. 2010;88(6):1157\u201369.","journal-title":"J Neurosci Res"},{"issue":"10","key":"35_CR46","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1101\/gr.122226.111","volume":"21","author":"JR Tollervey","year":"2011","unstructured":"Tollervey JR, Wang Z, Hortobagyi T, Witten JT, Zarnack K, Kayikci M, et al. Analysis of alternative splicing associated with aging and neurodegeneration in the human brain. Genome Res. 2011;21(10):1572\u201382.","journal-title":"Genome Res"},{"issue":"3","key":"35_CR47","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.yexcr.2006.10.028","volume":"313","author":"AT Weeraratna","year":"2007","unstructured":"Weeraratna AT, Kalehua A, Deleon I, Bertak D, Maher G, Wade MS, et al. Alterations in immunological and neurological gene expression patterns in Alzheimer\u2019s disease tissues. Exp Cell Res. 2007;313(3):450\u201361.","journal-title":"Exp Cell Res"},{"issue":"3","key":"35_CR48","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.mcn.2007.06.009","volume":"36","author":"PT Xu","year":"2007","unstructured":"Xu PT, Li YJ, Qin XJ, Kroner C, Green-Odlum A, Xu H, et al. A SAGE study of apolipoprotein E3\/3, E3\/4 and E4\/4 allele-specific gene expression in hippocampus in Alzheimer disease. Mol Cell Neurosci. 2007;36(3):313\u201331.","journal-title":"Mol Cell Neurosci"},{"issue":"2","key":"35_CR49","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.nbd.2005.07.004","volume":"21","author":"PT Xu","year":"2006","unstructured":"Xu PT, Li YJ, Qin XJ, Scherzer CR, Xu H, Schmechel DE, et al. Differences in apolipoprotein E3\/3 and E4\/4 allele-specific gene expression in hippocampus in Alzheimer disease. Neurobiol Dis. 2006;21(2):256\u201375.","journal-title":"Neurobiol Dis"},{"key":"35_CR50","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Zhang B, Gaiteri C, Bodea LG, Wang Z, McElwee J, Podtelezhnikov AA, et al. Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer\u2019s disease. Cell. 2013;153(3):707-20. Most recent transcriptome analyses in Alzheimer disease. Network analyses identify hub genes on biological processes disrupted in Alzheimer disease.","DOI":"10.1016\/j.cell.2013.03.030"},{"key":"35_CR51","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Rhinn H, Fujita R, Qiang L, Cheng R, Lee JH, Abeliovich A. Integrative genomics identifies APOE epsilon4 effectors in Alzheimer\u2019s disease. Nature. 2013;500(7460):45-50. Identifies a handful of genes responsible for increased A\u03b2 levels in carriers of the common APOE \u03b54 risk allele for late-onset AD.","DOI":"10.1038\/nature12415"},{"issue":"Pt 12","key":"35_CR52","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1093\/brain\/awq258","volume":"133","author":"K Bossers","year":"2010","unstructured":"Bossers K, Wirz KT, Meerhoff GF, Essing AH, van Dongen JW, Houba P, et al. Concerted changes in transcripts in the prefrontal cortex precede neuropathology in Alzheimer\u2019s disease. Brain. 2010;133(Pt 12):3699\u2013723.","journal-title":"Brain."},{"issue":"12","key":"35_CR53","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.neurobiolaging.2006.08.004","volume":"28","author":"OC Maes","year":"2007","unstructured":"Maes OC, Xu S, Yu B, Chertkow HM, Wang E, Schipper HM. Transcriptional profiling of Alzheimer blood mononuclear cells by microarray. Neurobiol Aging. 2007;28(12):1795\u2013809.","journal-title":"Neurobiol Aging"},{"key":"35_CR54","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/978-94-007-2888-2_54","volume":"740","author":"NK Woods","year":"2012","unstructured":"Woods NK, Padmanabhan J. Neuronal calcium signaling and Alzheimer\u2019s disease. Adv Exp Med Biol. 2012;740:1193\u2013217.","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"35_CR55","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1046\/j.1471-4159.1999.0721030.x","volume":"72","author":"JG Begley","year":"1999","unstructured":"Begley JG, Duan W, Chan S, Duff K, Mattson MP. Altered calcium homeostasis and mitochondrial dysfunction in cortical synaptic compartments of presenilin-1 mutant mice. J Neurochem. 1999;72(3):1030\u20139.","journal-title":"J Neurochem"},{"issue":"4","key":"35_CR56","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s00259-005-1762-7","volume":"32","author":"L Mosconi","year":"2005","unstructured":"Mosconi L. Brain glucose metabolism in the early and specific diagnosis of Alzheimer\u2019s disease. FDG-PET studies in MCI and AD. Eur J Nucl Med Mol Imaging. 2005;32(4):486\u2013510.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2-3","key":"35_CR57","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.bbadis.2004.09.008","volume":"1739","author":"K Iqbal","year":"2005","unstructured":"Iqbal K, Alonso Adel C, Chen S, Chohan MO, El-Akkad E, Gong CX, et al. Tau pathology in Alzheimer disease and other tauopathies. Biochim Biophys Acta. 2005;1739(2-3):198\u2013210.","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"35_CR58","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/cm.20388","volume":"66","author":"JR Bamburg","year":"2009","unstructured":"Bamburg JR, Bloom GS. Cytoskeletal pathologies of Alzheimer disease. Cell Motil Cytoskelet. 2009;66(8):635\u201349.","journal-title":"Cell Motil Cytoskelet."},{"issue":"5","key":"35_CR59","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.devcel.2008.09.017","volume":"15","author":"TY Huang","year":"2008","unstructured":"Huang TY, Minamide LS, Bamburg JR, Bokoch GM. Chronophin mediates an ATP-sensing mechanism for cofilin dephosphorylation and neuronal cofilin-actin rod formation. Dev Cell. 2008;15(5):691\u2013703.","journal-title":"Dev Cell"},{"issue":"3","key":"35_CR60","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.ajpath.2011.05.047","volume":"179","author":"A Serrano-Pozo","year":"2011","unstructured":"Serrano-Pozo A, Mielke ML, Gomez-Isla T, Betensky RA, Growdon JH, Frosch MP, et al. Reactive glia not only associates with plaques but also parallels tangles in Alzheimer\u2019s disease. Am J Pathol. 2011;179(3):1373\u201384.","journal-title":"Am J Pathol"},{"issue":"5","key":"35_CR61","doi-asserted-by":"crossref","first-page":"a005777","DOI":"10.1101\/cshperspect.a005777","volume":"4","author":"M Sheng","year":"2012","unstructured":"Sheng M, Sabatini BL, Sudhof TC. Synapses and Alzheimer\u2019s disease. Cold Spring Harb Perspect Biol. 2012;4(5):a005777.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"3","key":"35_CR62","doi-asserted-by":"crossref","first-page":"e4936","DOI":"10.1371\/journal.pone.0004936","volume":"4","author":"C Williams","year":"2009","unstructured":"Williams C, Mehrian Shai R, Wu Y, Hsu YH, Sitzer T, Spann B, et al. Transcriptome analysis of synaptoneurosomes identifies neuroplasticity genes overexpressed in incipient Alzheimer\u2019s disease. PLoS One. 2009;4(3):e4936.","journal-title":"PLoS One"},{"issue":"11","key":"35_CR63","doi-asserted-by":"crossref","first-page":"e1003049","DOI":"10.1371\/journal.pgen.1003049","volume":"8","author":"R Ruggiero","year":"2012","unstructured":"Ruggiero R, Kale A, Thomas B, Baker NE. Mitosis in neurons: Roughex and APC\/C maintain cell cycle exit to prevent cytokinetic and axonal defects in Drosophila photoreceptor neurons. PLoS Genet. 2012;8(11):e1003049.","journal-title":"PLoS Genet"},{"issue":"1","key":"35_CR64","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/path.2912","volume":"225","author":"Y Liu","year":"2011","unstructured":"Liu Y, Liu F, Grundke-Iqbal I, Iqbal K, Gong CX. Deficient brain insulin signalling pathway in Alzheimer\u2019s disease and diabetes. J Pathol. 2011;225(1):54\u201362.","journal-title":"J Pathol."},{"issue":"5","key":"35_CR65","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1091\/mbc.E08-07-0777","volume":"20","author":"HK Lee","year":"2009","unstructured":"Lee HK, Kumar P, Fu Q, Rosen KM, Querfurth HW. The insulin\/Akt signaling pathway is targeted by intracellular beta-amyloid. Mol Biol Cell. 2009;20(5):1533\u201344.","journal-title":"Mol Biol Cell"},{"issue":"2","key":"35_CR66","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.neurobiolaging.2008.04.002","volume":"31","author":"AM Moloney","year":"2010","unstructured":"Moloney AM, Griffin RJ, Timmons S, O\u2019Connor R, Ravid R, O\u2019Neill C. Defects in IGF-1 receptor, insulin receptor and IRS-1\/2 in Alzheimer\u2019s disease indicate possible resistance to IGF-1 and insulin signalling. Neurobiol Aging. 2010;31(2):224\u201343.","journal-title":"Neurobiol Aging"},{"issue":"7","key":"35_CR67","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1073\/pnas.0308512100","volume":"101","author":"EM Blalock","year":"2004","unstructured":"Blalock EM, Geddes JW, Chen KC, Porter NM, Markesbery WR, Landfield PW. Incipient Alzheimer\u2019s disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proc Natl Acad Sci USA. 2004;101(7):2173\u20138.","journal-title":"Proc Natl Acad Sci USA."},{"issue":"1","key":"35_CR68","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.neurobiolaging.2003.03.001","volume":"25","author":"G Bartzokis","year":"2004","unstructured":"Bartzokis G. Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer\u2019s disease. Neurobiol Aging. 2004;25(1):5\u201318 author reply 49\u201362.","journal-title":"Neurobiol Aging"},{"issue":"12","key":"35_CR69","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1089\/ars.2011.4173","volume":"16","author":"K Leuner","year":"2012","unstructured":"Leuner K, Schutt T, Kurz C, Eckert SH, Schiller C, Occhipinti A, et al. Mitochondrion-derived reactive oxygen species lead to enhanced amyloid beta formation. Antioxid Redox Signal. 2012;16(12):1421\u201333.","journal-title":"Antioxid Redox Signal"},{"issue":"5","key":"35_CR70","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jalz.2009.12.004","volume":"6","author":"MA Calciano","year":"2010","unstructured":"Calciano MA, Zhou W, Snyder PJ, Einstein R. Drug treatment of Alzheimer\u2019s disease patients leads to expression changes in peripheral blood cells. Alzheimers Dement. 2010;6(5):386\u201393.","journal-title":"Alzheimers Dement."},{"issue":"1","key":"35_CR71","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3233\/JAD-2012-120637","volume":"32","author":"P Fehlbaum-Beurdeley","year":"2012","unstructured":"Fehlbaum-Beurdeley P, Sol O, Desire L, Touchon J, Dantoine T, Vercelletto M, et al. Validation of AclarusDx, a blood-based transcriptomic signature for the diagnosis of Alzheimer\u2019s disease. J Alzheimers Dis. 2012;32(1):169\u201381.","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"35_CR72","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/gps.1260","volume":"20","author":"M Ankarcrona","year":"2005","unstructured":"Ankarcrona M, Winblad B. Biomarkers for apoptosis in Alzheimer\u2019s disease. Int J Geriatr Psychiatry. 2005;20(2):101\u20135.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"3","key":"35_CR73","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/00002093-200207000-00005","volume":"16","author":"M Bergman","year":"2002","unstructured":"Bergman M, Salman H, Beloosesky Y, Djaldetti M, Bessler H. Are peripheral blood cells from patients with Alzheimer disease more sensitive to apoptotic stimuli? Alzheimer Dis Assoc Disord. 2002;16(3):156\u201360.","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"6","key":"35_CR74","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2217\/nmt.12.68","volume":"2","author":"AL Metti","year":"2012","unstructured":"Metti AL, Cauley JA. How predictive of dementia are peripheral inflammatory markers in the elderly? Neurodegener Dis Manag. 2012;2(6):609\u201322.","journal-title":"Neurodegener Dis Manag."},{"issue":"1","key":"35_CR75","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3233\/JAD-2010-101518","volume":"23","author":"BB Booij","year":"2011","unstructured":"Booij BB, Lindahl T, Wetterberg P, Skaane NV, Saebo S, Feten G, et al. A gene expression pattern in blood for the early detection of Alzheimer\u2019s disease. J Alzheimers Dis. 2011;23(1):109\u201319.","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"35_CR76","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.nbd.2011.05.023","volume":"43","author":"KD Chen","year":"2011","unstructured":"Chen KD, Chang PT, Ping YH, Lee HC, Yeh CW, Wang PN. Gene expression profiling of peripheral blood leukocytes identifies and validates ABCB1 as a novel biomarker for Alzheimer\u2019s disease. Neurobiol Dis. 2011;43(3):698\u2013705.","journal-title":"Neurobiol Dis"},{"issue":"1","key":"35_CR77","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jalz.2009.07.001","volume":"6","author":"P Fehlbaum-Beurdeley","year":"2010","unstructured":"Fehlbaum-Beurdeley P, Jarrige-Le Prado AC, Pallares D, Carriere J, Guihal C, Soucaille C, et al. Toward an Alzheimer\u2019s disease diagnosis via high-resolution blood gene expression. Alzheimers Dement. 2010;6(1):25\u201338.","journal-title":"Alzheimers Dement."},{"issue":"6","key":"35_CR78","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nm1781","volume":"14","author":"T Town","year":"2008","unstructured":"Town T, Laouar Y, Pittenger C, Mori T, Szekely CA, Tan J, et al. Blocking TGF-beta-Smad2\/3 innate immune signaling mitigates Alzheimer-like pathology. Nat Med. 2008;14(6):681\u20137.","journal-title":"Nat Med"},{"issue":"1","key":"35_CR79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00041444-200503000-00001","volume":"15","author":"J Kalman","year":"2005","unstructured":"Kalman J, Kitajka K, Pakaski M, Zvara A, Juhasz A, Vincze G, et al. Gene expression profile analysis of lymphocytes from Alzheimer\u2019s patients. Psychiatr Genet. 2005;15(1):1\u20136.","journal-title":"Psychiatr Genet"},{"key":"35_CR80","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3389\/fpsyt.2012.00054","volume":"3","author":"A Wolf","year":"2012","unstructured":"Wolf A, Bauer B, Hartz AM. ABC Transporters and the Alzheimer\u2019s Disease Enigma. Front Psychiatry. 2012;3:54.","journal-title":"Front Psychiatry."},{"issue":"2","key":"35_CR81","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1471-4159.2006.03764.x","volume":"97","author":"SD Ginsberg","year":"2006","unstructured":"Ginsberg SD, Che S, Wuu J, Counts SE, Mufson EJ. Down regulation of trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer\u2019s disease. J Neurochem. 2006;97(2):475\u201387.","journal-title":"J Neurochem"},{"issue":"41","key":"35_CR82","doi-asserted-by":"crossref","first-page":"14854","DOI":"10.1073\/pnas.0504178102","volume":"102","author":"Y Nagasaka","year":"2005","unstructured":"Nagasaka Y, Dillner K, Ebise H, Teramoto R, Nakagawa H, Lilius L, et al. A unique gene expression signature discriminates familial Alzheimer\u2019s disease mutation carriers from their wild-type siblings. Proc Natl Acad Sci USA. 2005;102(41):14854\u20139.","journal-title":"Proc Natl Acad Sci USA."},{"issue":"1","key":"35_CR83","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.tibtech.2010.09.007","volume":"29","author":"C Humpel","year":"2011","unstructured":"Humpel C. Identifying and validating biomarkers for Alzheimer\u2019s disease. Trends Biotechnol. 2011;29(1):26\u201332.","journal-title":"Trends Biotechnol"}],"container-title":["Current Genetic Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40142-014-0035-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40142-014-0035-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40142-014-0035-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T12:50:03Z","timestamp":1716641403000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40142-014-0035-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,29]]},"references-count":83,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["35"],"URL":"https:\/\/doi.org\/10.1007\/s40142-014-0035-9","relation":{},"ISSN":["2167-4876"],"issn-type":[{"value":"2167-4876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,29]]}}}